SEC Info  
    Home      Search      My Interests      Help      Sign In      Please Sign In

United Therapeutics Corp. – ‘8-K’ for 4/1/21 – ‘XML’

On:  Thursday, 4/1/21, at 6:03am ET   ·   For:  4/1/21   ·   Accession #:  1104659-21-45097   ·   File #:  0-26301

Previous ‘8-K’:  ‘8-K’ on 3/3/21 for 3/2/21   ·   Next:  ‘8-K’ on / for 4/19/21   ·   Latest:  ‘8-K’ on / for 3/29/24

Find Words in Filings emoji
 
  in    Show  and   Hints

  As Of               Filer                 Filing    For·On·As Docs:Size             Issuer                      Filing Agent

 4/01/21  United Therapeutics Corp.         8-K:8,9     4/01/21   11:236K                                   Toppan Merrill/FA

Current Report   —   Form 8-K
Filing Table of Contents

Document/Exhibit                   Description                      Pages   Size 

 1: 8-K         Current Report                                      HTML     28K 
 2: EX-99.1     Miscellaneous Exhibit                               HTML     24K 
 7: R1          Cover                                               HTML     46K 
 9: XML         IDEA XML File -- Filing Summary                      XML     11K 
 6: XML         XBRL Instance -- tm2111622d1_8k_htm                  XML     15K 
 8: EXCEL       IDEA Workbook of Financial Reports                  XLSX      6K 
 4: EX-101.LAB  XBRL Labels -- uthr-20210401_lab                     XML     96K 
 5: EX-101.PRE  XBRL Presentations -- uthr-20210401_pre              XML     64K 
 3: EX-101.SCH  XBRL Schema -- uthr-20210401                         XSD     12K 
10: JSON        XBRL Instance as JSON Data -- MetaLinks               25±    33K 
11: ZIP         XBRL Zipped Folder -- 0001104659-21-045097-xbrl      Zip     18K 


‘XML’   —   XBRL Instance — tm2111622d1_8k_htm


This Document is an XBRL XML File.


                                                                                                                                                                                
<?xml version="1.0" encoding="windows-1252"?>
<xbrl xmlns="http://www.xbrl.org/2003/instance" xmlns:dei="http://xbrl.sec.gov/dei/2020-01-31" xmlns:iso4217="http://www.xbrl.org/2003/iso4217" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink">
<link:schemaRef xlink:href="uthr-20210401.xsd" xlink:type="simple"/>
<context id="From2021-04-01to2021-04-01">
<entity>
<identifier scheme="http://www.sec.gov/CIK"> 0001082554 </identifier>
</entity>
<period>
<startDate> 2021-04-01 </startDate>
<endDate> 2021-04-01 </endDate>
</period>
</context>
<unit id="USD">
<measure> iso4217:USD </measure>
</unit>
<unit id="Shares">
<measure> shares </measure>
</unit>
<unit id="USDPShares">
<divide>
<unitNumerator>
<measure> iso4217:USD </measure>
</unitNumerator>
<unitDenominator>
<measure> shares </measure>
</unitDenominator>
</divide>
</unit>
<dei:EntityCentralIndexKey contextRef="From2021-04-01to2021-04-01"> 0001082554 </dei:EntityCentralIndexKey>
<dei:AmendmentFlag contextRef="From2021-04-01to2021-04-01"> false </dei:AmendmentFlag>
<dei:DocumentType contextRef="From2021-04-01to2021-04-01"> 8-K </dei:DocumentType>
<dei:DocumentPeriodEndDate contextRef="From2021-04-01to2021-04-01"> 2021-04-01 </dei:DocumentPeriodEndDate>
<dei:EntityRegistrantName contextRef="From2021-04-01to2021-04-01"> United Therapeutics Corporation </dei:EntityRegistrantName>
<dei:EntityIncorporationStateCountryCode contextRef="From2021-04-01to2021-04-01"> DE </dei:EntityIncorporationStateCountryCode>
<dei:EntityFileNumber contextRef="From2021-04-01to2021-04-01"> 000-26301 </dei:EntityFileNumber>
<dei:EntityTaxIdentificationNumber contextRef="From2021-04-01to2021-04-01"> 52-1984749 </dei:EntityTaxIdentificationNumber>
<dei:EntityAddressAddressLine1 contextRef="From2021-04-01to2021-04-01"> 1040 Spring Street </dei:EntityAddressAddressLine1>
<dei:EntityAddressCityOrTown contextRef="From2021-04-01to2021-04-01"> Silver Spring </dei:EntityAddressCityOrTown>
<dei:EntityAddressStateOrProvince contextRef="From2021-04-01to2021-04-01"> MD </dei:EntityAddressStateOrProvince>
<dei:EntityAddressPostalZipCode contextRef="From2021-04-01to2021-04-01"> 20910 </dei:EntityAddressPostalZipCode>
<dei:CityAreaCode contextRef="From2021-04-01to2021-04-01"> 301 </dei:CityAreaCode>
<dei:LocalPhoneNumber contextRef="From2021-04-01to2021-04-01"> 608-9292 </dei:LocalPhoneNumber>
<dei:WrittenCommunications contextRef="From2021-04-01to2021-04-01"> false </dei:WrittenCommunications>
<dei:SolicitingMaterial contextRef="From2021-04-01to2021-04-01"> false </dei:SolicitingMaterial>
<dei:PreCommencementTenderOffer contextRef="From2021-04-01to2021-04-01"> false </dei:PreCommencementTenderOffer>
<dei:PreCommencementIssuerTenderOffer contextRef="From2021-04-01to2021-04-01"> false </dei:PreCommencementIssuerTenderOffer>
<dei:Security12bTitle contextRef="From2021-04-01to2021-04-01"> Common Stock, par value $0.01 per share </dei:Security12bTitle>
<dei:TradingSymbol contextRef="From2021-04-01to2021-04-01"> UTHR </dei:TradingSymbol>
<dei:SecurityExchangeName contextRef="From2021-04-01to2021-04-01"> NASDAQ </dei:SecurityExchangeName>
<dei:EntityEmergingGrowthCompany contextRef="From2021-04-01to2021-04-01"> false </dei:EntityEmergingGrowthCompany>
</xbrl>

Top
Filing Submission 0001104659-21-045097   –   Alternative Formats (Word / Rich Text, HTML, Plain Text, et al.)

Copyright © 2024 Fran Finnegan & Company LLC – All Rights Reserved.
AboutPrivacyRedactionsHelp — Fri., Apr. 26, 4:49:26.1pm ET